Diadema Partners »

Ventyx Biosciences shares owned by Diadema Partners

Quarter-by-quarter ownership of Ventyx Biosciences (VTYX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Ventyx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ventyx Biosciences held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ventyx Biosciences by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $221k 71k 3.11

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Ventyx Biosciences

Affinity Asset Advisors
Vanguard Group
Point72 Asset Management
Tang Capital Management
Marshall Wace
Vestal Point Capital
Citadel Advisors
Millennium Management
Ikarian Capital
BlackRock
Sectoral Asset Management
Redmile Group
Connor, Clark & Lunn Investment Management
Baker Bros. Advisors
683 Capital Management

View all funds holding Ventyx Biosciences